Zhi-Yong Xiao Selected Research

p-coumaric acid

10/2022	P-Coumaric Acid Reverses Depression-Like Behavior and Memory Deficit Via Inhibiting AGE-RAGE-Mediated Neuroinflammation.
7/2020	[p-Coumaric acid ameliorates chronic restraint stress induced memory deficit through BDNF in mice].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhi-Yong Xiao Research Topics

Disease

2	Memory Disorders (Memory Loss) 10/2022 - 07/2020
2	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 04/2020
2	Glomerulonephritis 11/2012 - 10/2007
2	Proteinuria 11/2012 - 10/2007
2	Bronchiolitis Obliterans Syndrome 11/2012 - 10/2007
2	Autoimmune Diseases (Autoimmune Disease) 12/2007 - 10/2007
1	Neuroinflammatory Diseases 10/2022
1	Inflammation (Inflammations) 10/2022
1	Infertility (Sterility) 01/2022
1	Pain (Aches) 01/2021
1	Hydrocephalus (Hydrocephaly) 12/2019
1	Mood Disorders (Mood Disorder) 11/2019
1	Cognitive Dysfunction 11/2019
1	Ischemic Stroke 08/2018
1	Brain Ischemia (Cerebral Ischemia) 08/2018
1	Brain Infarction 08/2018
1	Reperfusion Injury 08/2018
1	Edema (Dropsy) 01/2016
1	Necrosis 01/2016
1	Neoplasms (Cancer) 01/2016
1	Wounds and Injuries (Trauma) 01/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2013
1	Adenocarcinoma 05/2013
1	Encephalocele (Encephalocele, Frontal) 12/2010
1	Syringomyelia (Morvan's Disease) 12/2010
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2007
1	Nephritis 10/2007

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 04/2020 - 08/2018
2	CytokinesIBA 10/2022 - 10/2007
2	p-coumaric acidIBA 10/2022 - 07/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2022 - 12/2007
2	Immunologic Factors (Immunomodulators)IBA 12/2007 - 10/2007
2	roquinimexIBA 12/2007 - 10/2007
1	Receptor for Advanced Glycation End ProductsIBA 10/2022
1	Advanced Glycation End ProductsIBA 10/2022
1	Interleukin-1beta (Interleukin 1 beta)IBA 10/2022
1	Urocanic AcidIBA 01/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 07/2020
1	Angiopoietin-1IBA 04/2020
1	Sirtuin 1IBA 11/2019
1	dihydromyricetinIBA 11/2019
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 08/2018
1	Meglumine FDA Link 08/2018
1	Cyclic AMP (AMP, Cyclic)IBA 08/2018
1	Carrier Proteins (Binding Protein)IBA 08/2018
1	ElementsIBA 08/2018
1	GinkgolidesIBA 08/2018
1	DiterpenesIBA 08/2018
1	Neuroprotective AgentsIBA 08/2018
1	Mustard Gas (Sulfur Mustard)IBA 01/2016
1	NAD (NADH)IBA 01/2016
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2016
1	Poly (ADP-Ribose) Polymerase-1IBA 01/2016
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2016
1	veliparibIBA 01/2016
1	Adenosine Triphosphate (ATP)IBA 01/2016
1	bufalinIBA 05/2013
1	Triglycerides (Triacylglycerol)IBA 11/2012
1	NitrogenIBA 11/2012
1	AntibodiesIBA 11/2012
1	Urea (Carbamide)FDA LinkGeneric 11/2012
1	DNA (Deoxyribonucleic Acid)IBA 11/2012
1	Therapeutic UsesIBA 12/2010
1	Mitogen-Activated Protein KinasesIBA 12/2007
1	NF-kappa B (NF-kB)IBA 12/2007
1	Immunoglobulin G (IgG)IBA 10/2007

Therapy/Procedure

1	Therapeutics 01/2022
1	Conscious Sedation 01/2021
1	Analgesia 01/2021
1	Ventriculostomy 12/2019
1	Ventriculoperitoneal Shunt 12/2019
1	Intravenous Injections 11/2012
1	Oral Administration 10/2007